Mint Tower Capital Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Mint Tower Capital Management’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,796	Closed	-$963K	–	531
2022 Q2	$963K	Buy	+12,796	New	+$569K	0.08%	234

Mint Tower Capital Management's TPTX Position: Q3 2022 in Review

Mint Tower Capital Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 12,796 shares — an estimated $963K sold.

Mint Tower Capital Management first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $963K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Mint Tower Capital Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Mint Tower Capital Management sold 12,796 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $963K.
Mint Tower Capital Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Mint Tower Capital Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $963K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Mint Tower Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.